PMV Pharmaceuticals Inc. (PMVP)
1.02
0.02 (2.00%)
At close: Apr 17, 2025, 3:59 PM
1.00
-2.18%
After-hours: Apr 17, 2025, 07:56 PM EDT
2.00% (1D)
| Bid | 0.95 |
| Market Cap | 52.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -58.71M |
| EPS (ttm) | -1.16 |
| PE Ratio (ttm) | -0.88 |
| Forward PE | -0.6 |
| Analyst | Buy |
| Ask | 1.07 |
| Volume | 88,806 |
| Avg. Volume (20D) | 126,837 |
| Open | 0.97 |
| Previous Close | 1.00 |
| Day's Range | 0.95 - 1.04 |
| 52-Week Range | 0.82 - 2.26 |
| Beta | 1.49 |
About PMVP
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well a...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 25, 2020
Employees 47
Stock Exchange NASDAQ
Ticker Symbol PMVP
Website https://www.pmvpharma.com
Analyst Forecast
According to 2 analyst ratings, the average rating for PMVP stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 439.22% from the latest price.
Stock Forecasts